240 related articles for article (PubMed ID: 10028405)
1. Assessment of polystyrene extract for estrogenic activity in the rat uterotrophic model and an in vitro recombinant receptor reporter gene assay.
Fail PA; Hines JW; Zacharewski T; Wu ZF; Borodinsky L
Drug Chem Toxicol; 1998; 21 Suppl 1():101-21. PubMed ID: 10028405
[TBL] [Abstract][Full Text] [Related]
2. Uterotrophic assay of two concentrations of migrates from each of 23 polystyrenes administered orally (by gavage) to immature female Wistar rats.
Bachmann S; Hellwig J; Jäckh R; Christian MS
Drug Chem Toxicol; 1998; 21 Suppl 1():1-30. PubMed ID: 10028402
[TBL] [Abstract][Full Text] [Related]
3. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters.
Zacharewski TR; Meek MD; Clemons JH; Wu ZF; Fielden MR; Matthews JB
Toxicol Sci; 1998 Dec; 46(2):282-93. PubMed ID: 10048131
[TBL] [Abstract][Full Text] [Related]
4. Variability in the uterotrophic response assay (an in vivo estrogenic response assay) in untreated control and positive control (DES-DP, 2.5 microG/kg, bid) Wistar and Sprague-Dawley rats.
Christian MS; Hoberman AM; Bachmann S; Hellwig J
Drug Chem Toxicol; 1998; 21 Suppl 1():51-100. PubMed ID: 10028404
[TBL] [Abstract][Full Text] [Related]
5. Comparative estrogenic effects of p-nonylphenol by 3-day uterotrophic assay and female pubertal onset assay.
Kim HS; Shin JH; Moon HJ; Kang IH; Kim TS; Kim IY; Seok JH; Pyo MY; Han SY
Reprod Toxicol; 2002; 16(3):259-68. PubMed ID: 12128099
[TBL] [Abstract][Full Text] [Related]
6. Potential estrogenic and antiestrogenic activity of the cyclic siloxane octamethylcyclotetrasiloxane (D4) and the linear siloxane hexamethyldisiloxane (HMDS) in immature rats using the uterotrophic assay.
McKim JM; Wilga PC; Breslin WJ; Plotzke KP; Gallavan RH; Meeks RG
Toxicol Sci; 2001 Sep; 63(1):37-46. PubMed ID: 11509742
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
8. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro.
Connor K; Howell J; Chen I; Liu H; Berhane K; Sciarretta C; Safe S; Zacharewski T
Fundam Appl Toxicol; 1996 Mar; 30(1):93-101. PubMed ID: 8812239
[TBL] [Abstract][Full Text] [Related]
9. Validation of the intact rat weanling uterotrophic assay with notes on the formulation and analysis of the positive control chemical in vehicle.
Tyl RW; Marr MC; Brown SS; Dolbow EA; Myers CB
J Appl Toxicol; 2010 Oct; 30(7):694-8. PubMed ID: 20981862
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of styrene oligomers eluted from polystyrene for estrogenicity in estrogen receptor binding assay, reporter gene assay, and uterotrophic assay.
Ohno K; Azuma Y; Date K; Nakano S; Kobayashi T; Nagao Y; Yamada T
Food Chem Toxicol; 2003 Jan; 41(1):131-41. PubMed ID: 12453737
[TBL] [Abstract][Full Text] [Related]
11. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S
Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800
[TBL] [Abstract][Full Text] [Related]
12. The effects of phytoestrogens on neonatal rat uterine growth and development.
Medlock KL; Branham WS; Sheehan DM
Proc Soc Exp Biol Med; 1995 Mar; 208(3):307-13. PubMed ID: 7878071
[TBL] [Abstract][Full Text] [Related]
13. Immature rat uterotrophic assay of bisphenol A.
Yamasaki K; Sawaki M; Takatsuki M
Environ Health Perspect; 2000 Dec; 108(12):1147-50. PubMed ID: 11133394
[TBL] [Abstract][Full Text] [Related]
14. Potential estrogenic effects of bisphenol-A estimated by in vitro and in vivo combination assays.
Kim HS; Han SY; Yoo SD; Lee BM; Park KL
J Toxicol Sci; 2001 Aug; 26(3):111-8. PubMed ID: 11552294
[TBL] [Abstract][Full Text] [Related]
15. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
16. Examination of the estrogenicity of 2,4,6,2',6'-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2',6'-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2',4',6'-hexachlorobiphenyl (PCB 155).
Fielden MR; Chen I; Chittim B; Safe SH; Zacharewski TR
Environ Health Perspect; 1997 Nov; 105(11):1238-48. PubMed ID: 9370515
[TBL] [Abstract][Full Text] [Related]
17. Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.
Ramamoorthy K; Vyhlidal C; Wang F; Chen I; Safe S; McDonnell DP; Leonard LS; Gaido KW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):93-100. PubMed ID: 9356311
[TBL] [Abstract][Full Text] [Related]
18. Preparation and analysis of styrene oligomers containing migrates from various polystyrenes used in food packaging.
Klärner P; Klenz R; Eder R; Volz WE; Schnell HW; Leyendecker D; Güntner A; Niessner N; Morris CR; Christian MS
Drug Chem Toxicol; 1998; 21 Suppl 1():31-49. PubMed ID: 10028403
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions.
Takeyoshi M; Yamasaki K; Sawaki M; Nakai M; Noda S; Takatsuki M
Toxicol Lett; 2002 Jan; 126(2):91-8. PubMed ID: 11751013
[TBL] [Abstract][Full Text] [Related]
20. Uterotrophic assay of percutaneous lavender oil in immature female rats.
Politano VT; McGinty D; Lewis EM; Hoberman AM; Christian MS; Diener RM; Api AM
Int J Toxicol; 2013; 32(2):123-9. PubMed ID: 23358464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
